UPDATE : Monday, September 7, 2020
상단여백
Court suspends FSC’s disciplinary action against Samsung BioLogics
The Seoul Administrative Court Tuesday suspended the Financial Services Com...
by Lee Han-soo  |  2019-02-20 12:12
라인
Chong Kun Dang unveils trial results for erectile dysfunction treatment
Chong Kun Dang said Monday that it has presented the clinical trial results...
by Lee Han-soo  |  2019-02-19 17:36
라인
Yuhan’s sales reached ₩1.5 trillion in 2018
Yuhan Corp. said Monday that it recorded 1.5 trillion won ($1.3 billion) in...
by Lee Han-soo  |  2019-02-19 16:06
라인
Pharma Research Bio wins nod to export botulinum toxin
Pharma Research Bio said it obtained approval from the Ministry of Food and...
by Lee Hye-seon  |  2019-02-19 15:46
라인
[News Focus] Will MSD’s new antidiabetic SGLT-2 inhibitor prove effective?
Whether MSD’s ertugliflozin, a new antidiabetic SGLT-2 (sodium-glucose cotr...
by Kim Yun-mi  |  2019-02-19 14:31
라인
Does anticoagulant Eliquis work on children?
The Ministry of Food and Drug Safety has allowed BMS Korea to conduct a pha...
by Lee Hye-seon  |  2019-02-19 10:53
라인
Technoclone to supply Handok diagnostic reagent for ADAMTS-13 activity test
Handok said Monday that it has signed an agreement with Technoclone, an Aus...
by Lee Han-soo  |  2019-02-18 16:38
라인
‘Hair loss drug Propesia works well for Koreans in long term’
MSD Korea’s Propesia (ingredient: finasteride), which has been used as male...
by Kim Yun-mi  |  2019-02-18 16:38
라인
Hanmi’s RaboneD dominates osteoporosis therapy market
Hanmi Pharmaceutical’s RaboneD, an osteoporosis treatment in the selective ...
by Kim Yun-mi  |  2019-02-18 14:23
라인
Humedix posts record-high sales in Q4 sales
Humedix said Friday that its earnings turned around and has posted record-h...
by Lee Han-soo  |  2019-02-18 14:22
라인
Ministry OKs Peptron’s P2 clinical trial of Parkinson’s disease treatment
Peptron said Monday that the Ministry of Food and Drug Safety has approved ...
by Lee Han-soo  |  2019-02-18 11:13
라인
Sillajen’s research selected as cover paper for international journal
Sillajen said Friday that the Clinical Cancer Research, an international jo...
by Lee Han-soo  |  2019-02-15 17:36
라인
SK Biopharmaceuticals, Arvelle to develop, commercialize cenobamate in Europe
SK Biopharmaceuticals said Thursday that it has signed an exclusive licensi...
by Lee Han-soo  |  2019-02-15 15:36
라인
Acute myeloid leukemia treatment Rydapt approved as orphan drug
The regulatory agency approved Rydapt 25mg (ingredient: midostaurin), a tre...
by Lee Hye-seon  |  2019-02-15 15:36
라인
Sanofi Genzyme Korea launches rare blood disorder franchise
Sanofi Genzyme Korea, a subsidiary of Sanofi, said Thursday that it has lau...
by Lee Han-soo  |  2019-02-15 14:37
라인
GC starts P2 trials of hepatitis B treatment
GC said Thursday that it has administered the first dose of GC1102, a new r...
by Lee Han-soo  |  2019-02-15 14:36
라인
MSD leads rapidly growing antidiabetic DPP-4 inhibitors market
MSD took the No. 1 position in sales of antidiabetic dipeptidyl peptidase-4...
by Kim Yun-mi  |  2019-02-15 14:31
라인
Dong-A ST posts ₩567.2 billion in 2018 sales
Dong-A ST said Wednesday that it recorded the sales of 567.2 billion ($504....
by Lee Han-soo  |  2019-02-14 16:13
라인
Blood-thinning NOAC market expands 30% in 2018
The domestic market of non-vitamin K antagonist oral anticoagulants (NOAC) ...
by Kim Yun-mi  |  2019-02-14 12:12
라인
Yuhan’s subsidiary wins ₩43.5 billion funding
ImmuneOncia Therapeutics said Wednesday that it has completed a private equ...
by Lee Han-soo  |  2019-02-13 17:04
여백
여백
여백
Back to Top